Harry interviews Andrew A. Radin, co-founder and CEO of twoXAR, an Artificial Intelligence driven drug discovery startup that unifies disparate data to identify potential disease treatments.
twoXAR Pharmaceuticals is now ARIA Pharmaceuticals. Read More